MAGNAPERA, ALESSIA
MAGNAPERA, ALESSIA
Dipartimento di Medicina Sperimentale
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R
Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles
2025-05-30 Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 30-mag-2025 | Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles | Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V | Articolo su rivista |